Companies Dominating the Lidocaine Landscape
- Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hisamitsu Pharmaceutical Co., Inc.
- Jiangsu Tianji Pharmaceutical Co. Ltd.
- Teikoku Pharma USA, Inc.
- Sorrento Therapeutics, Inc
- Olympus Corporation
- Endo Pharmaceutical Inc.
- Fujifilm Holdings Corporation
- Actavis Labs UT Inc.
- Dun & Bradstreet, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of lidocaine is evaluated at USD 995.01 million.
Lidocaine Market size was over USD 952.12 million in 2024 and is poised to exceed USD 1.86 billion by 2037, growing at over 5.3% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is poised to hold largest revenue share by 2037, on the back of spiraling number of dental and cosmetic procedures, along with plastic surgeries.
The major players in the market are Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Jiangsu Tianji Pharmaceutical Co. Ltd., Teikoku Pharma USA, Inc., Sorrento Therapeutics, Inc., and others.
